Write in a clean editor, then format for Frontiers in Clinical Diabetes and Healthcare in one click — DocuGuru applies the official Frontiers template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Frontiers in Clinical Diabetes and Healthcare is a peer-reviewed journal published by Frontiers, covering Diabetes Management and Research, Diabetes Management and Education, Diabetes, Cardiovascular Risks, and Lipoproteins. Over its lifetime it has published 413 papers, which have received 2,229 citations.
| Publisher | Frontiers |
|---|---|
| Reference style | Numbered (Vancouver) Numbered — [1], [2] in the text 1. Smith A, Jones B, Lee C. A representative article title. Frontiers in Clinical Diabetes and Healthcare. 2023;12(3):45–58.
Formats any DOI in Frontiers in Clinical Diabetes and Healthcare style. No sign-up. |
| Publishes research in | Diabetes Management and Research Diabetes Management and Education Diabetes, Cardiovascular Risks, and Lipoproteins Diabetes Treatment and Management Diabetes and associated disorders |
| ISSN | 2673-6616 |
| Citation impact (2-yr) | 2.12 |
| h-index | 20 |
| i10-index | 70 |
| Article processing charge | $1,900 |
| Open access | Yes — indexed in DOAJ |
| Top institutions publishing here | Diabetes Australia |
| Journal website | www.frontiersin.org |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Glucagon like peptide-1 (GLP-1) receptor agonists are well established drugs for the treatment of type 2 diabetes (T2D). In addition to glycemic control, GLP-1 receptor agonists have beneficial other effects. They act by binding to GLP-1 receptors, which are widely distributed in the body, including cardiomyocytes and blood vessels. The aim of this article is…
SPECIALTY GRAND CHALLENGE article Front. Clin. Diabetes Healthc., 04 November 2020Sec. Diabetes and Pregnancy Volume 1 - 2020 | https://doi.org/10.3389/fcdhc.2020.546256
OPINION article Front. Clin. Diabetes Healthc., 19 August 2022Sec. Diabetes Inequalities Volume 3 - 2022 | https://doi.org/10.3389/fcdhc.2022.895313
Aims: Measurement tools to evaluate self-management behavior are useful for diabetes research and clinical practice. The Diabetes Self-Management Questionnaire (DSMQ) was introduced in 2013 and has become a widely used tool. This article presents a revised and updated version, DSMQ-R, and evaluates its properties in assessing self-management practices in type 1 diabetes (T1D) and type…
Diabetes mellitus (DM) affects the metabolism of primary macronutrients such as proteins, fats, and carbohydrates. Due to the high prevalence of DM, emergency admissions for hyperglycemic crisis, diabetic ketoacidosis (DKA) and hyperglycemic hyperosmolar state (HHS) are fairly common and represent very challenging clinical management in practice. DKA and HHS are associated with high mortality rates…
